T-1095 is a selective and orally active Na + -glucose cotransporter ( SGLT ) inhibitor with IC 50 s of 22.8 µM and 2.3 µM for human SGLT1 and SGLT2 , respectively. T-1095 can be used for diabetes research.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > SGLT
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.